Hypertension is frequently present in patients with reflux esophagitis or Barrett's esophagus but not in those with non-ulcer dyspepsia

European Journal of Internal Medicine

Volumn 13, Issue 6, 2002, Pages 369-375

  Gudlaugsdottir, Sunna ^a   Verschuren, W M Monique ^b   Dees, Jan ^a   Stijnen, Theo ^c   Wilson, J H Paul ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Barrett's esophagus; Coronary heart disease; Esophageal cancer; Hypertension; Non ulcer dyspepsia; Reflux esophagitis

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BARRETT ESOPHAGUS; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSPEPSIA; FEMALE; GASTROINTESTINAL ENDOSCOPY; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; QUESTIONNAIRE; REFLUX ESOPHAGITIS;

EID: 0036754220     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0953-6205(02)00090-0     Document Type: Article

References (26)

1. Spechler S.J. Epidemiology and natural history of gastro-esophageal reflux disease. Digestion. 51:(Suppl 1):1992;24-29.
2. McDougall N.I., Johnston B.T., Kee F., Collins J.S., McFarland R.J., Love A.H. Natural history of reflux oesophagitis: a 10 year follow up of its effect on patient symptomatology and quality of life. Gut. 38:1996;481-486.
3. Naef A.P., Savary M., Ozzello L. Columnar-lined lower esophagus: An acquired lesion with malignant predisposition. Report on 140 cases of Barrett's esophagus with 12 adenocarcinomas. J Thorac Cardiovasc Surg. 70:1975;826-835.
4. Blot W.J., Devesa S.S., Kneller R.W., Fraumeni J.F. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. J Am Med Assoc. 265:1991;1287-1289.
5. van Sandick J.W., van Lanschot J.J., Kuiken B.W., Tytgat G.N., Offerhaus G.J., Obertop H. Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut. 43:1998;216-222.
6. Cameron A.J., Carpenter H.A. Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study. Am J Gastroenterol. 92:1997;586-591.
7. Spechler S.J., Robbins A.H., Rubins H.B., et al. Adenocarcinoma and Barrett's esophagus. An overrated risk? Gastroenterology. 87:1984;927-933.
8. Cameron A.J., Ott B.J., Payne W.S. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. New Engl J Med. 313:1985;857-859.
9. Van der Veen A.H., Dees J., Blankensteijn J.D., van Blankenstein M. Adenocarcinoma in Barrett's oesophagus: an overrated risk. Gut. 30:1989;14-18.
10. van der Burgh A., Dees J., Hop W.C.J., van Blankenstein M. Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus. Gut. 39:1996;5-8.
11. Sharma P., Morales T.G., Sampliner R.E. Short segment Barrett's esophagus: the need for standardization of the definition and of endoscopic criteria. Am J Gastroenterol. 93:1998;1033-1036.
12. Little A.G., DeMeester T.R., Kirchner P.T., O'Sullivan G.C., Skinner D.B. Pathogenesis of esophagitis in patients with gastroesophageal reflux. Surgery. 88:1980;101-107.
13. Houterman S., Verschuren W.M.M., Oomen C.M., Boersma-Cobbaert C.M., Kromhout D. Trends in total and HDL cholesterol and their determinants in The Netherlands between 1993 and 1997. Int J Epidemiol. 30:2001;1063-10670.
14. JNC . The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med. 157:1997;2413-2446.
15. WHO . 1999 World Health Organization - International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens. 17:1999;151-183.
16. Hofman A., Grobbee D.E., de Jong P.T., van den Ouweland V.M. Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol. 7:1991;403-422.
17. Pickering T.G. White coat hypertension: time for action. Circulation. 98:1998;1834-1836.
18. Bidlingmeyer I., Burnier M., Bidlingmeyer M., Waeber B., Brunner H.R. Isolated office hypertension: a prehypertensive state? J Hypertens. 14:1996;327-332.
19. Carretero O.A., Oparil S. Essential hypertension. Part I. Definition and etiology. Circulation. 101:2000;329-335.
20. Roberts R.J. Can self-reported data accurately describe the prevalence of overweight? Public Health. 109:1995;275-284.
21. Alvarez-Torices J.C., Franch-Nadal J., Alvarez-Guisasola F., Hernandez-Mejia R., Cueto-Espinar A. Self-reported height and weight and prevalence of obesity. Study in a Spanish population. Int J Obes Relat Metab Disord. 17:1993;663-667.
22. Trudgill N.J., Kapur K.C., Riley S.A. Familial clustering of reflux symptoms. Am J Gastroenterol. 94:1999;1172-1178.
23. Romero Y., Cameron A.J., Locke G.R. III, et al. Familial aggregation of gastroesophageal reflux in patients with Barrett's esophagus and esophageal adenocarcinoma. Gastroenterology. 113:1997;1449-1456.
24. Macdonald C.E., Wicks A.C., Playford R.J. Final results from 10 year cohort of patients undergoing surveillance for Barrett's oesophagus: observational study. Br Med J. 321:2000;1252-1255.
25. Spechler J.S., Lee E., Ahnen D., et al. Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease. J Am Med Assoc. 285:2001;2331-2338.
26. Gudlaugsdottir S., Romme A.M., Dees J., Wilson J.H.P. The prevalence of coronary heart disease and its risk factors in patients with Barrett's esophagus [abstract]. Eur J Gastroenterol Hepatol. 12:2000;A4.